Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Compass Therapeutics (CMPX) Revenue (2024)

Compass Therapeutics (CMPX) has disclosed Revenue for 1 consecutive years, with $850000.0 as the latest value for Q2 2024.

  • Quarterly Revenue changed N/A to $850000.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $850000.0 through Mar 2025, changed N/A year-over-year, with the annual reading at $850000.0 for FY2024, N/A changed from the prior year.
  • Revenue hit $850000.0 in Q2 2024 for Compass Therapeutics.
  • In the past five years, Revenue ranged from a high of $850000.0 in Q2 2024 to a low of $850000.0 in Q2 2024.